BioTuesdays

Category - Markets

Alector
Markets

BTIG starts Alector at buy; PT $28

BTIG initiated coverage of Alector (NASDAQ:ALEC) with a “buy” rating and $28 price target. The stock closed at $15.80 on Nov. 20. Alector is focused on the immune system of the brain as a major player in...

November 21, 2019
Calithera Biosciences
Markets

HCW starts Calithera Biosciences at buy; PT $7

H.C. Wainwright launched coverage of Calithera Biosciences (NASDAQ:CALA) with a “buy” rating and $7 price target. The stock closed at $3.38 on Nov. 18. Calithera is developing therapies that target cellular metabolic...

November 19, 2019
SELLAS Life Sciences
Markets

Maxim ups SELLAS to buy; sets PT $12

Maxim Group upgraded SELLAS Life Sciences (NASDAQ:SLS) to “buy” from “hold” with a price target of $12 after the company removed a financing overhang. The stock closed at $6.17 on Nov. 14. SELLAS ended the latest...

November 15, 2019
ResTORbio
Markets

SVB Leerink cuts ResTORbio to MP; PT to $2 from $40

SVB Leerink downgraded ResTORbio (NASDAQ:TORC) to “market perform” from “outperform” and slashed its price to $2 from $40 after a failure of first of the company’s two ongoing Phase 3 trials in respiratory infection...

November 15, 2019
Leap Therapeutics
Markets

HCW cuts Leap Therapeutics PT to $3.25 from $7.50

H.C. Wainwright lowered its price target for Leap Therapeutics (NASDAQ:LPTX) to $3.25 from $7.50 after the company decided to re-allocate resources and focus on advancing DKN-01, its anti-Dickkopf-1 antibody, while...

November 15, 2019
Genocea Biosciences
Markets

SVB Leerink starts Genocea Biosciences at OP; PT $7

SVB Leerink launched coverage of Genocea Biosciences (NASDAQ:GNCA) with an “outperform” rating and price target of $7. The stock closed at $2.24 on Nov. 14. “Our positive view is based on the promise of Genocea’s ATLAS...

November 15, 2019
Liminal BioSciences
Markets

Liminal BioSciences to begin trading on NASDAQ

Common shares of Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) were approved for trading on the Nasdaq Global Market, effective Nov. 18, under the ticker symbol, LMNL. The shares will continue to trade on the Toronto...

November 15, 2019
Motus GI Holdings
Markets

AGP cuts PT for Motus GI to $3.75 from $6

Alliance Global Partners lowered its price target for Motus GI Holdings (NASDAQ:MOTS) to $3.75 from $6, reflecting a lower sales multiple and reduced estimates after the company’s third quarter report. The stock closed...

November 15, 2019

Subscribe

Sign up to our weekly BioTuesdays newsletter.